Oncology Institute (DFPH) Return on Equity (2020 - 2026)

Oncology Institute (DFPH) has reported Return on Equity for 7 consecutive years, with 0.03% the latest figure, recorded in Q1 2026.

• Return on Equity for Q1 2026 came in at 0.03%, up 18.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.03% (up 18.0% YoY), and the FY2025 annual result was 0.1%, up 12.0% from the prior year.
• Return on Equity was 0.03% for Q1 2026 at Oncology Institute, down from 0.04% in the prior quarter.
• Over five years, Return on Equity peaked at 0.34% in Q2 2025 and troughed at 0.15% in Q1 2025.
• Average Return on Equity over 5 years is 0.01%, with a median of 0.0% recorded in 2023.
• The widest YoY moves for Return on Equity: up 36 bps in 2025, down 13 bps in 2025.
• Over 5 years, Return on Equity stood at 0.0% in 2022, then plunged by 106585 bps to 0.01% in 2023, then sank by 426 bps to 0.07% in 2024, then jumped by 164 bps to 0.04% in 2025, then sank by 37 bps to 0.03% in 2026.
• Per Business Quant data, the three most recent Return on Equity figures were 0.03% in Q1 2026, 0.04% in Q4 2025, and 0.06% in Q3 2025.